Sales 2024 * | - | Sales 2025 * | 1.04M 760K | Capitalization | 26.09M 19.03M |
---|---|---|---|---|---|
Net income 2024 * | -74M -53.98M | Net income 2025 * | -54M -39.39M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 25 x |
P/E ratio 2024 * |
-0.24
x | P/E ratio 2025 * |
-0.34
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.93% |
Latest transcript on Aptose Biosciences
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
1st Jan change | Capi. | |
---|---|---|
+19.78% | 42.68B | |
-2.28% | 42.4B | |
+45.21% | 40.04B | |
-6.20% | 28.31B | |
+6.89% | 24.94B | |
-21.25% | 18.96B | |
+30.40% | 12.3B | |
-2.76% | 11.95B | |
-3.38% | 11.55B |